Why Catalent Inc’s (CTLT) Stock Is Up 9.74%

By Jenna Brashear
February 05, 2024
Featured Tickers:
CTLT

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Catalent Inc before investing.

In this article, we go over a few key elements for understanding Catalent Inc’s stock price such as:

  • Catalent Inc’s current stock price and volume
  • Why Catalent Inc’s stock price changed recently
  • Upgrades and downgrades for CTLT from analysts
  • CTLT’s stock price momentum as measured by its relative strength

About Catalent Inc (CTLT)

Before we jump into Catalent Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Catalent, Inc. is engaged in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. The Company’s Biologics segment provides development and manufacturing of biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells (iPSCs); oncolytic viruses, and vaccines. It also provides formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges, and analytical development and testing services for large molecules. The Company’s Pharma and Consumer Health segment comprises capabilities for complex oral solids, softgel formulations, Zydis fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms, and clinical trial development and supply services.

Want to learn more about Catalent Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Catalent Inc.

Learn More About A+ Investor

Catalent Inc’s Stock Price as of Market Close

As of February 05, 2024, 4:00 PM, CST, Catalent Inc’s stock price was $59.82.

Catalent Inc is up 9.74% from its previous closing price of $54.51.

During the last market session, Catalent Inc’s stock traded between $52.03 and $54.98. Currently, there are 181.00 million shares of Catalent Inc stock available for purchase.

Unfortunately, Catalent Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Catalent Inc Stock Price History

Catalent Inc’s (CTLT) price is currently up 15.84% so far this month.

During the month of February, Catalent Inc’s stock price has reached a high of $60.20 and a low of $51.60.

Over the last year, Catalent Inc has hit prices as high as $74.49 and as low as $31.45. Year to date, Catalent Inc’s stock is up 32.9%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Catalent Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 02, 2024, there was 1 analyst who downgraded Catalent Inc’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Catalent Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Catalent Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Catalent Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Catalent Inc (CTLT) by visiting AAII Stock Evaluator.

Relative Price Strength of Catalent Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 02, 2024, Catalent Inc has a weighted four-quarter relative price strength of 7.40%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how Catalent Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Catalent Inc Stock Price: Bottom Line

As of February 5, 2024, Catalent Inc’s stock price is $59.82, which is up 9.74% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Catalent Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.